Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors

Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors

US Patent 9346809 · Granted May 24, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase 2024
Glucose sensitive insulins and uses thereof2023
Powdered composition comprising a complex between a cannabinoid and a basic ion 2022
Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase 2022
Insulin derivatives and the medical uses hereof2022
Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesteras2022
Bicyclic amines as novel JAK kinase inhibitors2020
5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid deri2020
Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceuti2017
Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceuti2017
Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceuti2017
Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceuti2017